Watching the opening session for the #FriendsOfCancerResearch Annual Meeting! First up: seamless trial designs for rare cancer drug development! You can watch live and online: secure-web.cisco.com/1-aSs6clrewX...

Excited to be speaking on November 4th Friends of Cancer Research annual meeting (#FriendsAM25)! I will be speaking on #ContributionOfEffect (#COE) You can still register online: secure-web.cisco.com/1-aSs6clrewX...

Our 2025 ACI series concluded with sessions at ACR Convergence (Oct. 23) and APSHO's JADPRO (Oct. 27). Thank you everyone who made this series a roaring success! Missed a program? Access enduring materials: https://www.sitcancer.org/edu/aci Jeffrey Sparks MD MMSc, Elad Sharon, MD, MPH

Measles is back Whooping cough is back Now, diphtheria is staging a return with large outbreaks now in Somalia, Sudan, Yemen and Chad — countries with civil wars or large populations of refugees where vaccination coverage is low... www.nytimes.com/2025/10/27/h... @stephanienolen.bsky.social

ESMO Presidential Dinner is Kicking Off in Berlin - Vivek Subbiah @viveksubbiah.bsky.social @myesmo.bsky.social oncodaily.com/voices/vivek... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025

@ptarantinomd.bsky.social explores safety optimization of the next frontier of antibody-drug conjugate development. #ESMO25

Lung Cancer Advances at ESMO25 with Stephen V Liu @stephenvliu.bsky.social @myesmo.bsky.social oncodaily.com/not-to-miss/... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025

Dr. @pashtoonkasi discussed precision therapy in GI cancer, young CRC is mostly rectal and left-sided, high Her2 in gall bladder cancer, RAS testing on tissue often isn’t back in 2 weeks, liquid biopsy picks up heterogeneity, fusions, resistance mechs, at 2025 @WIN_Consortium Symposium.

NRG-LU005 Trial at the ASTRO 67th Annual Meeting: Atezolizumab and BID Radiotherapy in Limited-Stage SCLC oncodaily.com/oncolibrary/... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #NRG-LU005 #ASTRO25 #SCLC

Elizabeth Mittendorf Named Chief of Multi-Disciplinary Oncology at Dana-Farber and Chief of Breast Surgery at BIDMC @danafarbernews.bsky.social @danafarber.bsky.social @bidmc-cancercenter.bsky.social oncodaily.com/career/eliza... #OncoDaily #Oncology #Cancer #Health #Medicine #MedOnc #MedNews

What an amazing assay. DAF-seq, the evolution of Fiber-seq from the Andrew Stergachis group, using the @pacbio.bsky.social platform: www.biorxiv.org/content/10.1... This will revolutionise our understanding of transcriptional regulation and functional non-coding variants.

Inflammation is a key driver of the pathophysiology of cardiometabolic disorders #obesity #T2D and new metabolic medicines based on GLP-1 action exert their magic in part by reducing inflammation. A new review from Professor Donath summarizes the field www.sciencedirect.com/science/arti...?

The Paris Summit of Synthetic Biology Centers, organized by @riceuniversity.bsky.social brought together global leaders of SynBio centers, biofoundries, and consortia to work out how to combine forces, grow expertise, fund discovery, and ensure ethical progress. A productive 2 days in Paris!

Olfactory dysfunction is common following SARS-CoV-2 infection, and can be detected on testing even in some who are unaware of having it/ don't report it (occult hyposmia) (US RECOVER study sample) #LongCovid jamanetwork.com/journals/jam...

Early Pancreatic Cancer Detection Improved with cfDNA Model-CD-AACR - Elizabeth McKenna @elizsmckenna.bsky.social oncodaily.com/voices/377561 #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PancreaticCancer

Join us in downtown Washington, DC next Saturday October 4th for the DC Lung Cancer Conference, an IASLC endorsed, 1-day CME meeting covering updates in lung cancer, featuring 58 thoughtful & dynamic faculty members. #DCLung25 Register today at medstarhealth.org/dclung25

Honored to Join Global Colleagues and Deliver the Message at the UN for The Last Mile Series - Vivek Subbiah @viveksubbiah.bsky.social oncodaily.com/voices/vivek... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Thanks to all who made our Chicago group meeting a success! It went by too quickly, but it’s always refreshing to see our #SWOGonc community in person. We're grateful for our donors 🙏 And for those who picked up some new @swog.org swag, we’re excited to see where you’ll be spotted wearing it!

A Meaningful Week of Science at the WCLC25 - Narjust Florez @narjustflorezmd.bsky.social oncodaily.com/voices/narju... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC25

Robin Zon Has Been Promoted to Chair of ASCO Society Board @ascocancer.bsky.social oncodaily.com/career/robin... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ASCO

‘One jab will do the job’: Pakistan begins rollout of HPV vaccine to millions of girls

Partitioning obesity by genomics, proteomics and health outcomes from >450,000 UK Biobank @naturemedicine.bsky.social —A protective subtype vs cardiometabolic diseases (GRS BFP) and —A risk subtype for these diseases (GRS uncoupling) GRS-genomic risk score nature.com/articles/s41...

1/ Thrilled to share that my main PhD article has just been published in Nature Human Behaviour! 🎉 👉 “A randomised controlled trial on the effect of administrative burden and information costs on social inequalities in early childcare access in France” rdcu.be/eFAEA

Caring Beyond the Diagnosis: UICC’s Global Impact on Cancer Support @uiccofficial.bsky.social oncodaily.com/voices/uicc-... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #UICC

On the Frontlines: Promoting Awareness of Young Lung Cancer - Narjust Florez @narjustflorezmd.bsky.social oncodaily.com/voices/narju... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #YoungLungCancer

Dr. Andy Wagner discusses advances and the ongoing research happening at @danafarber.bsky.social to better diagnose and treat cancer to improve outcomes for patients. Check out the story from Spectrum News 1 Worcester that aired as part of a #StandUp2Cancer special. ➡️ bit.ly/4mP2ZsZ

Moving to places that encourage more walking leads to more walking… @nature.com

Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial - The Lancet www.thelancet.com/journals/lan...

Can Macrophages Revolutionize Cancer Immunotherapy? - Yan Leyfman @yleyfman.bsky.social oncodaily.com/blog/yan-ley... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Immunotherapy #IO #Macrophages #CART

A pleasure to present alongside Drs @michael-jefford.bsky.social #DrLarissaNekhlyudov at today’s #MASCC25 Survivorship Workshop! Thank you to the attendees for your participation! @cancercaremascc.bsky.social

New data presented at #ASCO25 today by @danafarber.bsky.social's Sara Tolaney, MD, showed an ADC-immunotherapy combination resulted in durable responses with improved PFS among patients with metastatic TNBC when compared to standard treatment. ➡️ bit.ly/3HdmbB2

Thank you @maryamlustberg.bsky.social for sharing updates from @cancercaremascc.bsky.social to the @pallonccop.bsky.social !! Looking forward to participating/promoting the many great programs and initiatives! #oncsky #oncologynursing

NEWS FROM INDUSTRY Astra Zeneca reports that the POTOMAC Phase III trial demonstrated that adding 1yr durvalumab to standard Bacillus Calmette-Guérin induction and maintenance therapy significantly improved DGS in high-risk non-muscle-invasive #BladderCancer www.astrazeneca.com/media-centre...

Join nine clinical IO experts May 8! The SITC ACI: A Focus on Intratumoral Therapies, Vaccines and Cytokines program offers discussions on personalized cancer vaccines and free CME credits. Advance your knowledge: www.sitcancer.org/education/ac... @aporia64.bsky.social @eladsharonmd.bsky.social 🧪

Most vaccines don’t trigger mucosal IgA—a key airway defense Clever new Nat Comm study from 🇳🇴 solves that by fusing antigens to albumin, which uses FcRn pathway to cross the nasal barrier Result: a potent intranasal vaccine that protects vs. both flu and SARS-CoV-2 www.nature.com/articles/s41...

About to speak at the @theaacr.bsky.social annual meeting on side effects associated with cancer immunotherapy! If you are in Chicago, please come to S403b! It’s the place to be!

Our #TranslationalMedicine Link of the Week, chosen by @swog.org's Lee Ellis, MD, & Jimmy Rae, PhD: Microbiota-Centered Interventions to Boost Immune Checkpoint Blockade Therapies doi.org/10.1084/jem....

#myeloMATCH sub-study MM1OA-S03 is open! Patients registered to MYELOMATCH screening protocol who are 60+ or unfit for chemo and have AML w an IDH2 gene mutation may be assigned. Randomized to venetoclax + ASTX727 w/wo enasidenib. swog.org/clinical-trials/MM1OA-S03 @beatalleukemia.bsky.social

Complacency = Complicity

Clifton Mo, MD, provides an update on our ongoing clinical research to advance cutting-edge therapies for patients with multiple myeloma. https://bit.ly/3FfiSbx

S2212 SCARLET is a randomized @swog.org ph 3 trial of treatment de-escalation in early-stage #triplenegative #breastcancer, comparing neoadjuvant immunotherapy + chemo w/wo anthracyclines. #TNBC SWOG.org/clinical-trials/S2212 PI: Priyanka Sharma, MD @ibcresearch1.bsky.social @raalbany.bsky.social

Shortage Of Oncologists & Hematologists In US Projected To Exceed 2,000 By End Of Year @ascocancer.bsky.social @cliffordhudis.bsky.social @gohealio.bsky.social www.healio.com/news/hematol...

Our #TranslationalMedicine link of the week (#2 of 2), chosen by @swog.org's Lee Ellis, MD & Jimmy Rae, PhD: Integrating Artificial Intelligence in Drug Discovery and Early Drug Development: A Transformative Approach doi.org/10.1186/s403...

A study in Nature Neuroscience shows that brain inflammation in COVID-19 correlates with viral load, systemic inflammation and virus-sensing pattern recognition receptors. Microglial dysfunction occurs at sites of vascular inflammation with myelin injury and synapse loss. 🧪

Our group chair's blog: The S2212 De-Escalation Trial: Only in Public-Powered Research S2212 in triple-negative #breastcancer collects patient-reported outcomes to tell us whether shorter, anthracycline-free treatment is efficacious & easier for patients #bcsm www.swog.org/news-events/...

Researchers from Ohio State University Comprehensive Cancer Center-James Cancer Hospital, led by Dr. Marcos De Lima, have shed light on a critical aspect of CAR-T therapy 🧬—long-term complications.

New findings from Dr. Fobert Ferris & team of UNC Lineberger Comprehensive Cancer Center reveal how neoadjuvant combination ICI reshapes CD8+ T cell responses in head & neck cancer! 👇

Incredible story, very well told. At the intersection of purpose-driven scientific research, dedicated federal employees working tirelessly without credit for the public good, rare diseases under radar of the power of the market, and “healthcare” in the US. Sharing as a gift article: wapo.st/3DyAWgz

Great turnout for #StandUpForScience in #Boston. This city is home to some of the greatest research institutions and hospitals in the world. We will not be silenced.

Packed house at #BTOG25’s SC lung cancer session Dr @stephenvliu.bsky.social talks of need to ID those that do/don’t derive benefit, find biomarkers, review optimal sequencing & better understand evolving biology of #SCLC. Describes SCLC in ppl w no/light smoking history. #LCSM @btog.bsky.social